Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking (a) to ensure the provision of Pfizer vaccines to people who cannot take Moderna and (b) with ICBs which have insufficient supplies of the Pfizer vaccine in North Northumberland constituency.

The UK Health Security Agency (UKHSA) procures vaccines that have been approved by the Medicines and Healthcare products Regulatory Agency and are advised for use in COVID-19 booster programmes by the Joint Committee on Vaccination and Immunisation (JCVI). The make-up of vaccine availability can vary from campaign to campaign based on the latest JCVI and clinical advice and procured stock available.

Published advice in the COVID-19 Green book, chapter 14a recommends that those with known contraindications to COVID-19 vaccination should seek advice from a relevant specialist. This may include an allergy specialist, who can make a clinical assessment of the individual's risks and benefits of vaccination. If suitable, these individuals may be advised to be vaccinated in hospital under medical supervision.

During the 2025 Spring COVID-19 vaccination campaign, UKHSA did not receive any reports of supply issues in North Northumberland.

Vaccine deployment is managed by NHS England which works with the regional teams and integrated care boards to ensure the vaccine is readily available for those eligible, as per the JCVI advice. UKHSA has worked and continues to work with all deployment partners to ensure the supply and provision of vaccines.